|
| Center for Health Economics |
 |
| On November 22, Ross DeVol spoke about the economic burden of chronic disease at the International Summit Forum on Chinese Medical and Health System Reform hosted by Chinese Pharmaceutical Association, and Hunan Provincial Government. Click here to view presentation. |
By 2014, it is estimated that the health-care industry in the United States will account for 17 percent of the country's GDP, or more than $3 trillion. The Center for Health Economics studies the impact of this industry on the overall economy. Our health economists provide valuable data on the sector, assisting government and business leaders as they determine what policies and actions would drive solutions to our current and future health-care challenges.
The Milken Institute Center for Health Economics specializes in:
| • |
analyzing current and projected conditions that impact the role that health-care industries and organizations play in regional economic development and job creation |
| |
|
| • |
examining the impact that current health-care trends—including a growing elderly population and the rise of some chronic diseases, such as diabetes and heart disease—will have on businesses, individuals and the overall economy and providing recommendations for decision makers to reduce the growing burden of health-care costs |
| |
|
| • |
assessing the ability of global research institutions to transfer their important life-science discoveries into marketable projects—a powerful economic development tool. |
For more information, view a summary of the Center for Health Economics.
Contact:
Ross DeVol
Executive Director, Economic Research
rdevol@milkeninstitute.org
|
 |
|
Associates Breakfast With David Baltimore, Nobel Laureate in Medicine
February 10, 2010
@IF>
Associates Breakfast With John Lechleiter, President, CEO and Chairman of Eli Lilly & Co.
January 14, 2010
@IF>
California's Stem Cell Initiative: Mapping the New Frontier of Medicine
Dr. Alan Trounson, California Institute for Regenerative Medicine
January 22, 2009
@IF>
Milken Institute
Who Killed Health Care?
Regina Herzlinger
November 12, 2007
@IF>
Milken Institute
The Economic Burden of Chronic Disease
October 11, 2007
@IF>
Milken Institute
Financial Innovations for Faster Cures: Securitization of Medical Solutions II
December 13, 2005
@IF>
Bloomberg
New York, N.Y.
Financial Innovations for Faster Cures: Securitization of Medical Solutions I
November 29, 2005
@IF>
Milken Institute
Santa Monica, CA
|
| 2010 |
 |
 |
| 2009 |
 |
 |
| 2007 |
 |
 |
| 2006 |
 |
 |
|
Mind to Market: A Global Analysis of University Biotechnology Transfer and Commercialization
Date:
September
20, 2006
Ross DeVol and Armen Bedroussian, with Anna Babayan, Meggy Frye, Daniela Murphy, Tomas J. Philipson, Lorna Wallace, Perry Wong and Benjamin Yeo
|
|
Mind to Market: A Global Analysis of University Biotechnology Transfer and Commercialization [Executive Summary]
Date:
September
20, 2006
Ross DeVol and Armen Bedroussian, with Anna Babayan, Meggy Frye, Daniela Murphy, Tomas J. Philipson, Lorna Wallace, Perry Wong and Benjamin Yeo
|
| 2005 |
 |
 |
| 2004 |
 |
 |
| 2003 |
 |
 |
| 2002 |
 |
 |
| 2001 |
 |
 |
| 2000 |
 |
 |
| 1999 |
 |
 |
|